Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparator. (2015)

First Author: Palace J
Attributed to:  MRC Centre for Neuropsychiatric Genetics and Genomics funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1474-4422(15)00018-6

PubMed Identifier: 25841667

Publication URI: http://europepmc.org/abstract/MED/25841667

Type: Journal Article/Review

Volume: 14

Parent Publication: The Lancet. Neurology

Issue: 5

ISSN: 1474-4422